Humoral and cell-mediated immune response in patients with malignant melanoma.I. In vitro lymphocyte reactivity to pha and antigens following immunization (Q67313968)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 1975

Language	Label	Description	Also known as
English	Humoral and cell-mediated immune response in patients with malignant melanoma.I. In vitro lymphocyte reactivity to pha and antigens following immunization	scientific article published on 01 October 1975

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1175127%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to PHA and antigens following immunization (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1175127%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

Humoral and cell-mediated immune response in patients with malignant melanoma.I. In vitro lymphocyte reactivity to pha and antigens following immunization (English)

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

cell-mediated immunity

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1175127

29 August 2022

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

author name string

G. C. de Gast

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1175127

29 August 2022

T. H. The

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1175127

29 August 2022

H. Schraffordt Koops

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1175127

29 August 2022

H. A. Huiges

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1175127

29 August 2022

J. Oldhoff

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1175127

29 August 2022

H. O. Nieweg

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1175127

29 August 2022

language of work or name

0 references

publication date

1 October 1975

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1175127%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

number of pages

9

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%28197510%2936%3A4%3C1289%3A%3AAID-CNCR2820360415%3E3.0.CO%3B2-P

Portable Document Format

online access status

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1175127

20 October 2023

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1175127%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1175127%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1175127%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1289-1297

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1175127%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

Lymphocyte reactivity in cancer patients: Correlation with tumor histology and clinical stage

1

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis

2

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

The human immune response to alpha-haemocyanin of Helix pomatia.

3

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen.

4

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

Impaired immunologic reactivity and recurrence following cancer surgery

5

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

Lymphocyte response to P.H.A. in patients with non-lymphoid tumours.

6

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

Effect of serum from cancer patients on homologous lymphocyte cultures

7

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

Suppression of the tuberculin response in malignant disease

9

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

Immunosurveillance and cancer

10

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

Immunologic alterations in bronchogenic cancer. Sequential study

11

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

DELAYED HYPERSENSITIVITY RESPONSE TO DNFB IN SICK AND HEALTHY PERSONS

13

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

Effect of plasma from patients with carcinoma on in vitro lymphocyte transformation

16

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

Reduced lymphocyte transformation in breast cancer

19

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

Immunologic studies in patients with malignant melanoma in Uganda

20

1 reference

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

https://api.crossref.org/works/10.1002/1097-0142(197510)36:4%3C1289::AID-CNCR2820360415%3E3.0.CO;2-P

20 October 2023

Identifiers

10.1002/1097-0142(197510)36:4<1289::AID-CNCR2820360415>3.0.CO;2-P

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1175127%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1175127%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67313968&oldid=1993917560"